Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations

被引：0
作者：
Karine Lecointre
Laurence Pisanté
Francis Fauvelle
Serge Mazouz
机构：
[1] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service Pharmacie
[2] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service de Cardiologie
来源：
Clinical Drug Investigation | 2001年 / 21卷
关键词：
Root Mean Square Error; Digoxin; Total Clearance; Digoxin Concentration; Serum Digoxin Concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 232
页数：7
相关论文
共 50 条
  • [31] Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations
    T. D. Bjornsson
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1997, 22 : 1 - 14
  • [32] Clinical Consequences of a Miscalibrated Digoxin Immunoassay
    Lim, Aaron E.
    Tate, Jillian R.
    Clarke, David
    Norris, Ross L.
    Morris, Raymond G.
    Martin, Jennifer H.
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 104 - 109
  • [33] Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population
    Moffett, Brady S.
    Garner, April
    Zapata, Troy
    Orcutt, Jeffrey
    Niu, Mary
    Lopez, Keila N.
    [J]. CARDIOLOGY IN THE YOUNG, 2016, 26 (03) : 493 - 498
  • [34] Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses
    Peters, J
    Welker, HA
    Bullingham, R
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (02) : 133 - 140
  • [35] A Population Pharmacokinetic Analysis of the Influence of Nutritional Status of Digoxin in Hospitalized Korean Patients
    Choi, Soo An
    Yun, Hwi-yeol
    Lee, Eun Sook
    Shin, Wan Gyoon
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (03) : 389 - 400
  • [36] Nateglinide, a New Mealtime Glucose RegulatorLack of Pharmacokinetic Interaction with Digoxin in Healthy Volunteers
    Honghui Zhou
    Yulia H. Walter
    Harold Smith
    Damayanthi Devineni
    James F. McLeod
    [J]. Clinical Drug Investigation, 2000, 19 : 465 - 471
  • [37] Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives
    Monique Groen-Wijnberg
    Jan van Dijk
    Walter Krauwinkel
    Virginie Kerbusch
    John Meijer
    Reiner Tretter
    Wenhui Zhang
    Marcel van Gelderen
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 417 - 429
  • [38] Population Pharmacokinetics of Digoxin in Japanese PatientsA 2-Compartment Pharmacokinetic Model
    Eiji Yukawa
    Fumihiro Suematu
    Miho Yukawa
    Masao Minemoto
    Shigehiro Ohdo
    Shun Higuchi
    Yoshinobu Goto
    Toshinobu Aoyama
    [J]. Clinical Pharmacokinetics, 2001, 40 : 773 - 781
  • [39] Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses
    J. Peters
    H. A. Welker
    R. Bullingham
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1999, 24 : 133 - 140
  • [40] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07) : 800 - 808
12345